UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000024657
Receipt No. R000028247
Official scientific title of the study Study about outcomes of Lymph-drainage for human legs.
Date of disclosure of the study information 2016/11/01
Last modified on 2016/10/31 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Study about outcomes of Lymph-drainage for human legs.
Title of the study (Brief title) Outcomes of Lymph-drainage
Region
Japan

Condition
Condition Healthy people
Classification by specialty
Nursing Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To clarify the outcomes of Lymph-drainage.
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes The fegs with circumferences, composition of water,mascle and fat of each leg.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification NO
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment No need to know

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 One person per 2 times. First, a participant lay down, and the other day she has Lymph-drainage for 30 minutes.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
35 years-old <=
Age-upper limit

Not applicable
Gender Female
Key inclusion criteria Women who do not operated on her abdomin.
Key exclusion criteria Pregnant women
Target sample size 10

Research contact person
Name of lead principal investigator NAKAO, Fujiko
Organization Kumamoto University
Division name Graduate school of Health Sciences
Address 4-24-1,Kuhonji, Kumamoto-city, Kumamoto
TEL 096-373-5495
Email fu8nakao@kumamoto-u.ac.jp

Public contact
Name of contact person NAKAO, Fujiko
Organization Kumamoto University
Division name Graduate school of Health Sciences
Address 4-24-1,Kuhonji, Kumamoto-city, Kumamoto
TEL 096-373-5495
Homepage URL
Email fu8nakao@kumamoto-u.ac.jp

Sponsor
Institute Graduate school of Health Sciences, Kumamoto University
Institute
Department

Funding Source
Organization Japanese Governmental office
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization JAPAN

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 熊本大学医学部付属病院(熊本県)

Other administrative information
Date of disclosure of the study information
2016 Year 11 Month 01 Day

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 06 Month 30 Day
Anticipated trial start date
2016 Year 10 Month 31 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 10 Month 31 Day
Last modified on
2016 Year 10 Month 31 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028247